Prosecution Insights
Prosecution Insights
5 pending office actions • 4 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (40%) |
| No statute on record | 3 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FETTEROLF, BRANDON J | 1 | 49.5% | +14.6% |
| NESTOR, DONNA MICHELLE | 1 | 57.5% | +43.9% |
| SCHMIDT, IZABELA MARIA | 1 | 63.1% | +53.5% |
| GONZALEZ, LUISALBERTO | 1 | 61.4% | +47.4% |
| HUI, SAN MING R | 1 | 59.0% | +20.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17359714 | MODIFIED RELEASE FORMULATIONS OF MODIFIED FORMS OF TRIMETAZIDINE | GONZALEZ, LUISALBERTO | 128d overdue |
| 17614826 | METHODS OF ALTERING CARDIAC REMODELING USING COMPOUNDS THAT PROMOTE GLUCOSE OXIDATION | NESTOR, DONNA MICHELLE | 74d overdue |
| 17922890 | DOSING METHODS FOR TREATMENT OF CARDIOVASCULAR CONDITIONS | FETTEROLF, BRANDON J | 53d overdue |
| 17359726 | MODIFIED RELEASE FORMULATIONS OF MODIFIED FORMS OF TRIMETAZIDINE | HUI, SAN MING R | 17d overdue |
| 17439763 | METHODS OF TREATING CANCER USING TRIMETAZIDINE-BASED COMPOUNDS | SCHMIDT, IZABELA MARIA | 11d overdue |
| Art Unit | Apps |
|---|---|
| 1627 | 2 |
| 1626 | 1 |
| 1621 | 1 |
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17922890 | DOSING METHODS FOR TREATMENT OF CARDIOVASCULAR CONDITIONS | FETTEROLF, BRANDON J | 1626 | Other | Final Rejection | 53d overdue | Pending | Nov 02, 2022 |
| 17614826 | METHODS OF ALTERING CARDIAC REMODELING USING COMPOUNDS THAT PROMOTE GLUCOSE OXIDATION | NESTOR, DONNA MICHELLE | 1627 | §103 | Non-Final OA | 74d overdue | Pending | Nov 29, 2021 |
| 17439763 | METHODS OF TREATING CANCER USING TRIMETAZIDINE-BASED COMPOUNDS | SCHMIDT, IZABELA MARIA | 1621 | Other | Non-Final OA | 11d overdue | Pending | Sep 15, 2021 |
| 17359714 | MODIFIED RELEASE FORMULATIONS OF MODIFIED FORMS OF TRIMETAZIDINE | GONZALEZ, LUISALBERTO | 1624 | Other | Final Rejection | 128d overdue | Pending | Jun 28, 2021 |
| 17359726 | MODIFIED RELEASE FORMULATIONS OF MODIFIED FORMS OF TRIMETAZIDINE | HUI, SAN MING R | 1627 | §103 | Final Rejection | 17d overdue | Pending | Jun 28, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial